세계의 오믹스 랩 서비스 시장 보고서(2025년)
Omics Lab Services Global Market Report 2025
상품코드 : 1855938
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,661,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,629,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,596,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 오믹스 랩 서비스 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 945억 2,000만 달러에서 2025년에는 1,094억 7,000만 달러에 달하고, CAGR 15.8%로 확대될 것으로 보입니다. 기간 중 성장은 정부 자금 증가, 맞춤형 의료의 확대, 만성 질환의 높은 유병률, 정밀 종양학의 성장, 생명공학과 제약산업의 대두에 의한 것입니다.

오믹스 랩 서비스 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년까지 CAGR 15.5%로 확대되어 1,945억 2,000만 달러로 성장할 것으로 예상됩니다. 예측 기간의 성장 배경으로는 동반자 진단 증가, 액체 생체 이용률 증가, 임상시험의 세계화, 만성 질환의 유병률 증가, 생명 공학 투자 증가 등이 있습니다. 예측 기간의 주요 동향으로는 급속한 기술 진보, 인간 유전체 시퀀싱 제품 개발, 클라우드 분석 및 빅 데이터 플랫폼 통합, 멀티오믹스 통합, 제약 기업 간 협업 등이 있습니다.

유전성 질환의 유병률 증가는 오믹스 랩 서비스 시장의 확대를 촉진할 것으로 예측됩니다. 유전성 질환은 개인의 DNA의 돌연변이나 이상에 의해 유발되며, 유전되거나 자연적으로 발병할 수 있습니다. 그 진단 증가는 차세대 시퀀싱 및 기타 유전체 도구와 같은 기술의 진보로 인한 것이 크고, 이전에는 발견되지 않았거나 잘못 분류된 상태를 확인하는 능력이 향상되었습니다. 오믹스 랩 서비스는 복잡한 생물학적 데이터를 분석하여 유전자 변이 및 분자 변화를 검출하고 조기 진단 및 보다 맞춤 치료 접근을 가능하게 하는데 중요한 역할을 합니다. 예를 들어 2024년 10월 Cystic Fibrosis Trust는 2022년 1만 1,148명에서 2023년 1만 1,318명이 낭포성 섬유증으로 등록되어 전년대비 1.5% 증가했다고 보고했습니다. 이 추세는 오믹스 기반 진단제에 대한 수요 증가를 반영하여 시장 성장에 기여합니다.

오믹스 랩 서비스 시장의 주요 기업은 맞춤형 의료를 지원하고 통합 멀티오믹스 연구를 가능하게 하는 혁신적인 오믹스 분석 솔루션을 도입하고 있습니다. 이러한 서비스는 유전자, RNA, 단백질, 대사산물, 후성유전자의 대규모 분석을 수행하고, 생체 시스템의 이해를 깊게 하고, 다양한 헬스케어 용도를 지원하고 있습니다. 2022년 5월 한국의 바이오테크놀러지 기업인 Bertis Inc.는 질량 분석 기반 단백질체학와 독자적인 바이오인포매틱스 및 인공지능을 통합한 플랫폼인 Pan-omics Analysis Service & Solution(PASS)을 발표했습니다. PASS는 단백질 식별, 바이오마커 탐색, 데이터 분석 등의 서비스를 통해 임상 연구 및 의약품 개발을 지원합니다. 이 발매는 Bertis가 진단학에서 고급 오믹스 분석으로 전략적 전환을 도모했음을 보여주며, 질병 메커니즘에 대한 보다 깊은 통찰력을 제공하여 맞춤형 의료의 진전에 공헌합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

JHS
영문 목차

영문목차

Omics lab services refer to a comprehensive suite of laboratory offerings focused on analyzing the full range of biological molecules within a biological system. These services aim to provide a holistic understanding of how molecular components are structured, regulated, and interact to influence the function and organization of living organisms.

The primary types of services in omics lab services include genomics, transcriptomics, proteomics, metabolomics, and epigenomics. Genomics involves the study of an organism's complete DNA set, including all genes and their functions. These services are delivered through models such as contract services, in-house services, consultative services, collaborative research, and custom solutions, utilizing technologies such as next-generation sequencing (NGS), microarray analysis, mass spectrometry, chromatography, and bioinformatics tools. Applications span drug discovery, diagnostics, personalized medicine, and more. Key end-users include research institutions, pharmaceutical and biotechnology companies, academic institutions, and clinical laboratories.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The omics lab services market research report is one of a series of new reports from The Business Research Company that provides omics lab services market statistics, including omics lab services industry global market size, regional shares, competitors with an omics lab services market share, detailed omics lab services market segments, market trends and opportunities, and any further data you may need to thrive in the omics lab services industry. This omics lab services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The omics lab services market size has grown rapidly in recent years. It will grow from $94.52 billion in 2024 to $109.47 billion in 2025 at a compound annual growth rate (CAGR) of 15.8%. The growth in the historic period is attributed to increasing government funding, expansion of personalized medicine, high prevalence of chronic diseases, growth of precision oncology, and the rise of biotechnology and pharmaceutical industries.

The omics lab services market size is expected to see rapid growth in the next few years. It will grow to $194.52 billion in 2029 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to the rise in companion diagnostics, increasing use of liquid biopsies, globalization of clinical trials, increasing prevalence of chronic diseases, and increasing investments in biotechnology. Major trends in the forecast period include rapid technological advancements, development of the products for human genome sequencing, integration of cloud analytics and big-data platforms, multi-omics integration, and collaborations between pharmaceutical companies.

The growing prevalence of genetic diseases is expected to drive the expansion of the omics lab services market. Genetic diseases, caused by mutations or abnormalities in an individual's DNA, can be inherited or occur spontaneously. Their increasing diagnosis is largely due to advancements in technologies such as next-generation sequencing and other genomic tools, which have improved the ability to identify previously undetected or misclassified conditions. Omics lab services play a critical role in analyzing complex biological data to detect genetic mutations and molecular changes, enabling earlier diagnosis and more personalized treatment approaches. For example, in October 2024, the Cystic Fibrosis Trust reported that 11,318 individuals were registered with cystic fibrosis in 2023, up from 11,148 in 2022, marking a 1.5% year-over-year increase. This trend reflects a growing demand for omics-based diagnostics and is contributing to the market's growth.

Key players in the omics lab services market are introducing innovative omics analysis solutions to support personalized medicine and enable integrated multi-omics research. These services involve large-scale analysis of genes, RNA, proteins, metabolites, and epigenetic factors to better understand biological systems and support a range of healthcare applications. In May 2022, Bertis Inc., a biotechnology company based in South Korea, launched the Pan-omics Analysis Service & Solution (PASS), a platform that integrates mass spectrometry-based proteomics with proprietary bioinformatics and artificial intelligence. PASS supports clinical research and drug development through services such as protein identification, biomarker discovery, and data analytics. This launch marked Bertis's strategic shift from diagnostics to advanced omics analysis, providing deeper insights into disease mechanisms and helping advance personalized medicine.

In July 2024, Anacura, a healthcare and life sciences company based in Belgium, acquired ohmX.bio NV for an undisclosed sum. This acquisition aims to enhance Anacura's capabilities in advanced multi-omics, supporting faster drug discovery and diagnostic development. It also reinforces Anacura's position as a comprehensive service provider within the Ghent biotech hub and the broader life sciences sector. ohmX.bio NV, also based in Belgium, specializes in omics solutions across genomics, transcriptomics, and epigenomics, strengthening Anacura's expertise in integrated omics research.

Major players in the omics lab services market are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Novogene Co. Ltd., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Macrogen Inc., MedGenome Labs Ltd., Metabolon Inc., Zymo Research Corporation, CD Genomics, BaseClear B.V., Strand Life Sciences Pvt. Ltd., Sengenics Corporation Pte Ltd., Psomagen Inc., Biocrates Life Sciences AG, Creative Proteomics.

North America was the largest region in the omics lab services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the Omics Lab Services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The omics lab services market includes revenues earned by entities by providing services such as whole genome sequencing, expression profiling, protein identification, biomarker discovery, and chromatin immunoprecipitation analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Omics Lab Services Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on omics lab services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for omics lab services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The omics lab services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Omics Lab Services Market Characteristics

3. Omics Lab Services Market Trends And Strategies

4. Omics Lab Services Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Omics Lab Services Growth Analysis And Strategic Analysis Framework

6. Omics Lab Services Market Segmentation

7. Omics Lab Services Market Regional And Country Analysis

8. Asia-Pacific Omics Lab Services Market

9. China Omics Lab Services Market

10. India Omics Lab Services Market

11. Japan Omics Lab Services Market

12. Australia Omics Lab Services Market

13. Indonesia Omics Lab Services Market

14. South Korea Omics Lab Services Market

15. Western Europe Omics Lab Services Market

16. UK Omics Lab Services Market

17. Germany Omics Lab Services Market

18. France Omics Lab Services Market

19. Italy Omics Lab Services Market

20. Spain Omics Lab Services Market

21. Eastern Europe Omics Lab Services Market

22. Russia Omics Lab Services Market

23. North America Omics Lab Services Market

24. USA Omics Lab Services Market

25. Canada Omics Lab Services Market

26. South America Omics Lab Services Market

27. Brazil Omics Lab Services Market

28. Middle East Omics Lab Services Market

29. Africa Omics Lab Services Market

30. Omics Lab Services Market Competitive Landscape And Company Profiles

31. Omics Lab Services Market Other Major And Innovative Companies

32. Global Omics Lab Services Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Omics Lab Services Market

34. Recent Developments In The Omics Lab Services Market

35. Omics Lab Services Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기